Copeptin’s Connection With Mortality in CKD
V. Krane, B. Genser, M.E. Kleber, et al. find that copeptin concentrations are independently associated with coronary, infectious, and all-cause mortality in patients with chronic kidney disease.
Image credit: Steve Snodgrass/Flickr
E.K.Y. Leung, E. Agolini, X. Pei, et al. show that the Invader and TaqMan assay combined panel provides a valid, highly accurate, and reproducible approach for CYP2D6 genotyping that could be implemented clinically.
In a first, the U.S. Food and Drug Administration has approved drug for cancer therapy based on tumor genetics rather than origin.
The shadow of prescription painkiller abuse now looms more ominously than ever before. Yet opioids remain a mainstay of pain management, upping the stakes for monitoring prescription compliance and detecting abuse.